While clinical labs’ use of machine learning and artificial intelligence is perhaps most prominently associated with areas like pathology and microbiology testing, these tools are also seeing uptake for lab management applications like specimen routing and billing support.These kinds of
The laboratory services joint venture that IQVIA and Quest Diagnostics have operated for the past six years is moving under the full control of IQVIA in a $760 million transaction. The cash sum is what IQVIA paid to acquire
By Karina Shah Lipocalin 2 (in red) is a protein found in tears that is made by the new organoidsYorick Post/Elsevier Miniature organoids that function like human tear glands have been grown in the lab – and they can produce
Electric vehicle maker Rivian has inked a deal with the University of Illinois to use its COVID-19 saliva tests in its factories in Illinois and California. The Amazon-backed startup donated $500,000 to U of I’s SHIELD COVID-19 testing program to
Everlywell, a leader in the at-home diagnostic testing space, has acquired PWNHealth and its subsidiary Home Access Health to form a new parent company called Everly Health. PWNHealth and Home Access Health both have self-collected lab test services, and by
For the first time, scientists have used human cells to make structures that mimic the earliest stages of development, which they say will pave the way for more research without running afoul of restrictions on using real embryos.Two papers published
Quest Diagnostics has entered an agreement to acquire the outreach laboratory services business of healthcare system Mercy, the companies announced this week.With the acquisition, Quest will pick up the business from 29 Mercy hospital labs and two independent clinic labs
A whistleblower who accused a COVID-19 testing lab she managed in California of improper work is being sued by the company for violating a confidentiality agreement.PerkinElmer Inc. sued Mahnaz Salem in federal court in Los Angeles on Monday, alleging she
Inspectors found “significant deficiencies” at California’s new coronavirus testing laboratory, problems that state officials on Monday partly blamed on the rapid ramp-up they required from the lab’s private operator under terms of a $1.4 billion contract.A fraction of 1% of
You have reached your limit of 4 free articles. Get unlimited access to TIME.com.99¢ for the first month Subscribe Now You have 1 free article left. Subscribe for just 99¢. This is your last free article. Subscribe for just 99¢.